Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 191

1.

Measuring the effectiveness of scientific gatekeeping.

Siler K, Lee K, Bero L.

Proc Natl Acad Sci U S A. 2014 Dec 22. pii: 201418218. [Epub ahead of print]

PMID:
25535380
[PubMed - as supplied by publisher]
2.

Conflicts of interest and critiques of the use of systematic reviews in policymaking: an analysis of opinion articles.

Forsyth SR, Odierna DH, Krauth D, Bero LA.

Syst Rev. 2014 Nov 18;3(1):122. doi: 10.1186/2046-4053-3-122.

PMID:
25417178
[PubMed - in process]
Free PMC Article
3.

A clearer view of evidence in treating macular degeneration: off-label policies and independent research.

Formoso G, Marata AM, Magrini N, Bero L.

Cochrane Database Syst Rev. 2014 Sep 15;9:ED000090. No abstract available.

PMID:
25313417
[PubMed - in process]
4.

Bias related to funding source in statin trials.

Bero L.

BMJ. 2014 Oct 3;349:g5949. doi: 10.1136/bmj.g5949. No abstract available.

PMID:
25281682
[PubMed - in process]
5.

Systematic reviews: perhaps "the answer to policy makers' prayers"?

Fox DM, Bero L.

Environ Health Perspect. 2014 Oct;122(10):A262-3. doi: 10.1289/ehp.1408599. No abstract available.

PMID:
25272205
[PubMed - in process]
Free PMC Article
6.

On WHO's essential medicines process and transparency.

Magrini N, Robertson J, de Joncheere K, Bero L.

BMJ. 2014 Sep 17;349:g5637. doi: 10.1136/bmj.g5637. No abstract available.

PMID:
25231094
[PubMed - in process]
7.

A clearer view of evidence in treating macular degeneration: off-label policies and independent research.

Formoso G, Marata AM, Magrini N, Bero L.

Cochrane Database Syst Rev. 2014 Sep 15;9:ED000090. doi: 10.1002/14651858.ED000090. No abstract available.

PMID:
25228121
[PubMed - in process]
8.

The Food and Drug Administration reports provided more data but were more difficult to use than the European Medicines Agency reports.

Schroll JB, Abdel-Sattar M, Bero L.

J Clin Epidemiol. 2015 Jan;68(1):102-7. doi: 10.1016/j.jclinepi.2014.06.019. Epub 2014 Aug 20.

PMID:
25150193
[PubMed - in process]
Free Article
9.

What is in a name? Nonfinancial influences on the outcomes of systematic reviews and guidelines.

Bero L.

J Clin Epidemiol. 2014 Nov;67(11):1239-41. doi: 10.1016/j.jclinepi.2014.06.015. Epub 2014 Aug 15. No abstract available.

PMID:
25132356
[PubMed - in process]
10.

Side effects are incompletely reported among systematic reviews in gastroenterology.

Mahady SE, Schlub T, Bero L, Moher D, Tovey D, George J, Craig JC.

J Clin Epidemiol. 2014 Aug 11. pii: S0895-4356(14)00272-8. doi: 10.1016/j.jclinepi.2014.06.016. [Epub ahead of print]

PMID:
25124168
[PubMed - as supplied by publisher]
11.

Evidence based medicine: looking forward and building on what we have learnt.

Tovey D, Churchill R, Bero L.

BMJ. 2014 Jul 9;349:g4508. doi: 10.1136/bmj.g4508. No abstract available.

PMID:
25008476
[PubMed - indexed for MEDLINE]
12.

Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials.

Anglemyer A, Horvath HT, Bero L.

Cochrane Database Syst Rev. 2014 Apr 29;4:MR000034. doi: 10.1002/14651858.MR000034.pub2. Review.

PMID:
24782322
[PubMed - in process]
13.

Staff Perceptions of an On-site Clinical Pharmacist Program in an Academic Emergency Department after One Year.

Coralic Z, Kanzaria HK, Bero L, Stein J.

West J Emerg Med. 2014 Mar;15(2):205-10. doi: 10.5811/westjem.2013.11.18069.

PMID:
24672613
[PubMed]
Free PMC Article
14.

Instruments for assessing risk of bias and other methodological criteria: Krauth et al. Respond.

Krauth D, Woodruff TJ, Bero L.

Environ Health Perspect. 2014 Mar;122(3):A67. doi: 10.1289/ehp.1307727R. No abstract available.

PMID:
24583480
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Term limits and the tobacco industry.

Apollonio DE, Glantz SA, Bero LA.

Soc Sci Med. 2014 Mar;104:1-5. doi: 10.1016/j.socscimed.2013.11.005. Epub 2013 Nov 15.

PMID:
24581055
[PubMed - indexed for MEDLINE]
16.

Why the Cochrane risk of bias tool should include funding source as a standard item.

Bero LA.

Cochrane Database Syst Rev. 2013 Dec 20;12:ED000075. No abstract available.

PMID:
24575439
[PubMed - indexed for MEDLINE]
17.

Nonindustry-sponsored preclinical studies on statins yield greater efficacy estimates than industry-sponsored studies: a meta-analysis.

Krauth D, Anglemyer A, Philipps R, Bero L.

PLoS Biol. 2014 Jan;12(1):e1001770. doi: 10.1371/journal.pbio.1001770. Epub 2014 Jan 21.

PMID:
24465178
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

World Health Organization recommendations are often strong based on low confidence in effect estimates.

Alexander PE, Bero L, Montori VM, Brito JP, Stoltzfus R, Djulbegovic B, Neumann I, Rave S, Guyatt G.

J Clin Epidemiol. 2014 Jun;67(6):629-34. doi: 10.1016/j.jclinepi.2013.09.020. Epub 2014 Jan 3. Review.

PMID:
24388966
[PubMed - indexed for MEDLINE]
19.

Availability, prices and affordability of essential medicines in Haiti.

Chahal HS, St Fort N, Bero L.

J Glob Health. 2013 Dec;3(2):020405. doi: 10.7189/jogh.03.020405.

PMID:
24363923
[PubMed]
Free PMC Article
20.

Interactions between non-physician clinicians and industry: a systematic review.

Grundy Q, Bero L, Malone R.

PLoS Med. 2013 Nov;10(11):e1001561. doi: 10.1371/journal.pmed.1001561. Epub 2013 Nov 26. Review.

PMID:
24302892
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk